p.86 抽出テキスト

ic right ventricular cardiomyopathy using a novel signalaveraging system based on Holter ECG. Circ Arrhythm Electrophysiol 2012; 5: 789-795. PMID: 22665699 247. Yoshioka K, Amino M, Zareba W, et al. Identification of highrisk Brugada syndrome patients by combined analysis of late potential and T-wave amplitude variability on ambulatory electrocardiograms. Circ J 2013; 77: 610-618. PMID: 23439592 248. Sobue Y, Watanabe E, Yamamoto M, et al. Beat-to-beat variability of T-wave amplitude for the risk assessment of ventricular tachyarrhythmia in patients without structural heart disease. Europace 2011; 13: 1612-1618. PMID: 21712269 249. Couderc JP, Zareba W, McNitt S, et al. Repolarization variability in the risk stratification of MADIT II patients. Europace 2007; 9: 717-723. PMID: 17639070 250. Kinoshita T, Hashimoto K, Yoshioka K, et al. Risk stratification for cardiac mortality using electrocardiographic markers based on 24-hour Holter recordings: the JANIES-SHD study. J Cardiol 2020; 75: 155-163. PMID: 31474497 251. Bauer A, Barthel P, Schneider R, et al. Improved stratification of autonomic regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J 2009; 30: 576-583. PMID: 19109245 252. Ikeda T, Saito H, Tanno K, et al. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol 2002; 89: 79-82. PMID: 11779531 253. Hohnloser SH, Klingenheben T, Zabel M, et al. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1999; 33: 1895- 1902. PMID: 10362190 254. Scirica BM, Braunwald E, Belardinelli L, et al. Relationship between nonsustained ventricular tachycardia after non-STelevation acute coronary syndrome and sudden cardiac death: Observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromethrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 2010; 122: 455- 462. PMID: 20644019 255. Zipes DP, et al. European Heart Rhythm Association. ACC/ AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2 0 0 6 ; 4 8 : e 2 4 7 -e 3 4 6 . PMID: 16949478 256. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000; 342: 1937-1945. PMID: 10874061 257. Daubert JP, Zareba W, Hall WJ, et al. MADIT II Study Investigators. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2006; 47: 98-107. PMID: 16386671 258. Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: Results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol 2012; 59: 37-45. PMID: 22192666 259. Takagi M, Sekiguchi Y, Yokoyama Y, et al. Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. The prognostic impact of single extra-stimulus on programmed ventricular stimulation in Brugada patients without previous cardiac arrest: multi-centre study in Japan. Europace 2018; 20: 1194- 1200. PMID: 29016800 260. Simson MB. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation 1981; 64: 235-242. PMID: 7249291 261. Breithardt G, Cain ME, el-Sherif N, et al. Standards for analysis of ventricular late potentials using high-resolution or signalaveraged electrocardiography: A statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol 1991; 17: 999-1006. PMID: 2007727 262. Gomes JA, Winters SL, Martinson M, et al. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: A prospective study. J Am Coll Cardiol 1989; 13: 377-384. PMID: 2464014 263. el-Sherif N, Denes P, Katz R, et al. The Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/ SAECG) Substudy Investigators. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol 1995; 25: 908-914. PMID: 7884096 264. Ikeda T, Yoshino H, Sugi K, et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: Results of a collaborative cohort study. J Am Coll Cardiol 2006; 48: 2268-2274. PMID: 17161258 265. Yodogawa K, Ohara T, Takayama H, et al. Detection of prior myocardial infarction patients prone to malignant ventricular arrhythmias using wavelet transform analysis. Int Heart J 2011; 52: 286-289. PMID: 22008437 266. Ikeda T, Sakurada H, Sakabe K, et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: Insight into risk stratification. J Am Coll Cardiol 2001; 37: 1628-1634. PMID: 11345376 267. Ciconte G, Santinelli V, Vicedomini G, et al. Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: clinical implications from a prospective clinical trial. Europace 2019; 21: 1900- 1910. PMID: 31647530 268. Mancini DM, Wong KL, Simson MB. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation 1993; 87: 1083-1092. PMID: 8462136 269. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. Circulation 2010; 121: 1533-1541. PMID: 20172911 270. Hashimoto K, Amino M, Yoshioka K, et al. Combined evaluation of ambulatory-based late potentials and nonsustained ventricular tachycardia to predict arrhythmic events in patients with previous myocardial infarction: A Japanese noninvasive electrocardiographic risk stratification of sudden cardiac death (JANIES) substudy. Ann Noninvasive Electrocardiol 2021; 26: e12803. PMID: 32969113 271. Ikeda T, Sakata T, Takami M, et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction: A prospective study. J Am Coll Cardiol 2000; 35: 722-730. PMID: 10716476 272. Rosenbaum DS, Jackson LE, Smith JM, et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994; 330: 235-241. PMID: 8272084 273. Hohnloser SH, Ikeda T, Bloomfield DM, et al. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 2003; 362: 125-126. PMID: 12867114 274. Hohnloser SH, Ikeda T, Cohen RJ. Evidence regarding clinical use of microvolt T-wave alternans. Heart Rhythm 2009; 6 Suppl: S36-S44. PMID: 19168396 275. Verrier RL, Klingenheben T, Malik M, et al. Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol 2011; 58: 1309-1324. PMID: 21920259 276. Costantini O, Hohnloser SH, Kirk MM, et al. ABCD Trial Investigators. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: Strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol 2009; 53: 471-479. PMID: 19195603 277. Chow T, Kereiakes DJ, Onufer J, et al. MASTER Trial Investigators. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol 2008; 52: 1607- 1615. PMID: 18992649 278. Calò L, De Santo T, Nuccio F, et al. Predictive value of microvolt T-wave alternans for cardiac death or ventricular tachyarrhythmic events in ischemic and nonischemic cardiomyopathy patients: A meta-analysis. Ann Noninvasive Electrocardiol 2011; 16: 388- 402. PMID: 22008495 279. Merchant FM, Ikeda T, Pedretti RF, et al. Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death. Heart Rhythm 2012; 9: 1256-1264. PMID: 22406384